Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:31097636  

Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.

Yu-Ru Lee | Ming Chen | Jonathan D Lee | Jinfang Zhang | Shu-Yu Lin | Tian-Min Fu | Hao Chen | Tomoki Ishikawa | Shang-Yin Chiang | Jesse Katon | Yang Zhang | Yulia V Shulga | Assaf C Bester | Jacqueline Fung | Emanuele Monteleone | Lixin Wan | Chen Shen | Chih-Hung Hsu | Antonella Papa | John G Clohessy | Julie Teruya-Feldstein | Suresh Jain | Hao Wu | Lydia Matesic | Ruey-Hwa Chen | Wenyi Wei | Pier Paolo Pandolfi
Science (New York, N.Y.) | 2019

Activation of tumor suppressors for the treatment of human cancer has been a long sought, yet elusive, strategy. PTEN is a critical tumor suppressive phosphatase that is active in its dimer configuration at the plasma membrane. Polyubiquitination by the ubiquitin E3 ligase WWP1 (WW domain-containing ubiquitin E3 ligase 1) suppressed the dimerization, membrane recruitment, and function of PTEN. Either genetic ablation or pharmacological inhibition of WWP1 triggered PTEN reactivation and unleashed tumor suppressive activity. WWP1 appears to be a direct MYC (MYC proto-oncogene) target gene and was critical for MYC-driven tumorigenesis. We identified indole-3-carbinol, a compound found in cruciferous vegetables, as a natural and potent WWP1 inhibitor. Thus, our findings unravel a potential therapeutic strategy for cancer prevention and treatment through PTEN reactivation.

Pubmed ID: 31097636

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA082328
  • Agency: NCI NIH HHS, United States
    Id: R01 CA200651
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL104030
  • Agency: NCI NIH HHS, United States
    Id: R35 CA197529

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.